Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in Vivo

This publication has 37 references indexed in Scilit:

• Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
  Cellular Signalling, 2002
• Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
• Advances in Rho-dependent actin regulation and oncogenic transformation
  Current Opinion in Genetics & Development, 2002
• RHO–GTPases and cancer
  Nature Reviews Cancer, 2002
• Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effect
  FEBS Letters, 2001
• Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion
  Seminars in Cancer Biology, 2001
• Rho signals to cell growth and apoptosis
  Cancer Letters, 2001
• Rho GTPases: Signaling, Migration, and Invasion
  Experimental Cell Research, 2000
• Genomic analysis of metastasis reveals an essential role for RhoC
  Nature, 2000
• Rho GTPases are over-expressed in human tumors
  International Journal of Cancer, 1999